Want to stay on top of the science and politics driving biotech today? Sign up t...
Aficamten is under clinical development by Cytokinetics and currently in Phase I...
TTI-101 is under clinical development by Tvardi Therapeutics and currently in Ph...
Ketamine ER is under clinical development by Douglas Pharmaceuticals and current...
SIM-325 is under clinical development by TCR Cure Biopharma Technology and curre...
Latozinemab is under clinical development by Alector and currently in Phase III ...
SGN-1 is under clinical development by Guangzhou Sinogen Pharmaceutical and curr...
RiMO-301 is under clinical development by Rimo Therapeutics and currently in Pha...
AZ-3102 is under clinical development by Azafaros and currently in Phase II for ...
J-2H1702 is under clinical development by J2H Biotech and currently in Phase II ...
NN-9440 is under clinical development by Inversago Pharma and currently in Phase...
Letters to the editor: “It's no wonder that ID doctors are some of the most burn...
In the latest edition of Health Tech newsletter: Takeda, Janssen team up with Ac...
Want to stay on top of the science and politics driving biotech today? Sign up t...
By Luisa Sterkel & Joana Loureiro, Tenthpin Consultants and Dr. Frank Altznauer...
Biocon subsidiary Biocon Biologics has successfully integrated Viatris' biosimi...